001     902537
005     20220103172046.0
024 7 _ |a 10.1136/jnnp-2021-326131
|2 doi
024 7 _ |a 0022-3050
|2 ISSN
024 7 _ |a 0266-8637
|2 ISSN
024 7 _ |a 0368-329X
|2 ISSN
024 7 _ |a 1468-330X
|2 ISSN
024 7 _ |a 2128/29047
|2 Handle
024 7 _ |a altmetric:113296831
|2 altmetric
024 7 _ |a pmid:34510000
|2 pmid
024 7 _ |a WOS:000722666700001
|2 WOS
037 _ _ |a FZJ-2021-04339
082 _ _ |a 610
100 1 _ |a Sauerbier, Anna
|0 0000-0003-0966-5933
|b 0
|e Corresponding author
245 _ _ |a Predictors of short-term impulsive and compulsive behaviour after subthalamic stimulation in Parkinson disease
260 _ _ |a London
|c 2021
|b BMJ Publishing Group
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1637218635_27541
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Background The effects of subthalamic stimulation (subthalamic nucleus-deep brain stimulation, STN-DBS) on impulsive and compulsive behaviours (ICB) in Parkinson’s disease (PD) are understudied.Objective To investigate clinical predictors of STN-DBS effects on ICB.Methods In this prospective, open-label, multicentre study in patients with PD undergoing bilateral STN-DBS, we assessed patients preoperatively and at 6-month follow-up postoperatively. Clinical scales included the Questionnaire for Impulsive-Compulsive Disorders in PD-Rating Scale (QUIP-RS), PD Questionnaire-8, Non-Motor Symptom Scale (NMSS), Unified PD Rating Scale in addition to levodopa-equivalent daily dose total (LEDD-total) and dopamine agonists (LEDD-DA). Changes at follow-up were analysed with Wilcoxon signed-rank test and corrected for multiple comparisons (Bonferroni method). We explored predictors of QUIP-RS changes using correlations and linear regressions. Finally, we dichotomised patients into ‘QUIP-RS improvement or worsening’ and analysed between-group differences.Results We included 55 patients aged 61.7 years±8.4 with 9.8 years±4.6 PD duration. QUIP-RS cut-offs and psychiatric assessments identified patients with preoperative ICB. In patients with ICB, QUIP-RS improved significantly. However, we observed considerable interindividual variability of clinically relevant QUIP-RS outcomes as 27.3% experienced worsening and 29.1% an improvement. In post hoc analyses, higher baseline QUIP-RS and lower baseline LEDD-DA were associated with greater QUIP-RS improvements. Additionally, the ‘QUIP-RS worsening’ group had more severe baseline impairment in the NMSS attention/memory domain.Conclusions Our results show favourable ICB outcomes in patients with higher preoperative ICB severity and lower preoperative DA doses, and worse outcomes in patients with more severe baseline attention/memory deficits. These findings emphasise the need for comprehensive non-motor and motor symptoms assessments in patients undergoing STN-DBS.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Loehrer, Philipp
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Jost, Stefanie T.
|0 0000-0003-0477-2289
|b 2
700 1 _ |a Heil, Shania
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Petry-Schmelzer, Jan N.
|0 0000-0003-0749-3840
|b 4
700 1 _ |a Herberg, Johanna
|0 P:(DE-HGF)0
|b 5
700 1 _ |a Bachon, Pia
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Aloui, Salima
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Gronostay, Alexandra
|0 P:(DE-HGF)0
|b 8
700 1 _ |a Klingelhoefer, Lisa
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Baldermann, J. Carlos
|0 0000-0001-5851-9268
|b 10
700 1 _ |a Huys, Daniel
|0 0000-0002-9124-4128
|b 11
700 1 _ |a Nimsky, Christopher
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Barbe, Michael T.
|0 P:(DE-Juel1)131613
|b 13
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 14
700 1 _ |a Martinez-Martin, Pablo
|0 P:(DE-HGF)0
|b 15
700 1 _ |a Ray Chaudhuri, K.
|0 P:(DE-HGF)0
|b 16
700 1 _ |a Visser-Vandewalle, Veerle
|0 P:(DE-HGF)0
|b 17
700 1 _ |a Timmermann, Lars
|0 P:(DE-HGF)0
|b 18
700 1 _ |a Weintraub, Daniel
|0 P:(DE-HGF)0
|b 19
700 1 _ |a Dafsari, Haidar S.
|0 0000-0001-8849-4233
|b 20
773 _ _ |a 10.1136/jnnp-2021-326131
|g Vol. 92, no. 12, p. 1313 - 1318
|0 PERI:(DE-600)1480429-3
|n 12
|p 1313 - 1318
|t Journal of neurology, neurosurgery, and psychiatry
|v 92
|y 2021
|x 0022-3050
856 4 _ |u https://juser.fz-juelich.de/record/902537/files/Sauerbier_2021_J%20Neurol%20Neurosurg%20Psychiatry_Predictors%20of%20short-term...pdf
|y OpenAccess
909 C O |o oai:juser.fz-juelich.de:902537
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 14
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2021-01-27
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL NEUROSUR PS : 2019
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-01-27
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2021-01-27
915 _ _ |a Allianz-Lizenz
|0 StatID:(DE-HGF)0410
|2 StatID
|d 2021-01-27
|w ger
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL NEUROSUR PS : 2019
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-01-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-01-27
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2021-01-27
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-01-27
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21